Skip to content
Merito
← Back to results
EB-2 NIWBiotech and pharmaIndividualDecided February 2025Dismissed

Outcome: Dismissed

FEB272025_04B5203

Merit and national importanceNot metWell positionedNot reached / not discussedBalance favors a waiverNot reached / not discussed

Our summary

A biomedical scientist and clinical pathology technician sought EB-2 with national interest waiver. The AAO dismissed the appeal, holding that the proposed biomedical company's services and training would not extend beyond individual clients to have national importance or broader field impact.

Official PDF

Official PDF ↗

Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.

No criterion in the table was found met in this decision.

What was missing

  • Merit and national importance · Company services would not extend beyond individual clients; business plan lacks evidence of field-wide impact or substantial economic effects

Criteria

CriterionReadingWhy
Merit and national importanceNot metCompany services would not extend beyond individual clients; business plan lacks evidence of field-wide impact or substantial economic effects
Well positionedNot reached / not discussedNot reached because first prong failed; issue is dispositive
Balance favors a waiverNot reached / not discussedNot reached because first prong failed; issue is dispositive

A published decision describes one case. It is not legal advice and not a prediction for yours.

Similar decisions

Decisions whose text is closest to this one.